• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Oppenheimer initiated coverage on Sutro Biopharma with a new price target

    10/6/23 7:43:30 AM ET
    $STRO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $STRO alert in real time by email
    Oppenheimer initiated coverage of Sutro Biopharma with a rating of Outperform and set a new price target of $10.00
    Get the next $STRO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $STRO

    DatePrice TargetRatingAnalyst
    6/16/2025$2.00Neutral → Overweight
    Piper Sandler
    3/17/2025Buy → Neutral
    H.C. Wainwright
    3/14/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    3/14/2025$8.00 → $2.00Outperform → Neutral
    Wedbush
    3/14/2025$11.00 → $1.00Buy → Underperform
    BofA Securities
    5/8/2024$12.00Buy
    BofA Securities
    11/9/2023$12.00Buy
    Deutsche Bank
    10/6/2023$10.00Outperform
    Oppenheimer
    More analyst ratings

    $STRO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Wigginton Jon Marc

      4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)

      6/10/25 4:14:14 PM ET
      $STRO
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form 4 filed by Director Petree Daniel H

      4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)

      6/10/25 4:13:33 PM ET
      $STRO
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form 4 filed by Director Panek James P

      4 - SUTRO BIOPHARMA, INC. (0001382101) (Issuer)

      6/10/25 4:12:50 PM ET
      $STRO
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care